283
Participants
Start Date
January 31, 2009
Primary Completion Date
December 31, 2019
Study Completion Date
June 30, 2020
NIRFLI with ICG
We conduct Near-infrared Fluorescence Lymphatic Imaging following the off-label use of Indocyanine Green as a lymph contrast agent and the use of a custom designed fluorescence imager to dynamically follow lymphatic trafficking in subjects. We seek to use the resulting phenotypes acquired in normal and diseased patients to correlate to mutations of specific genes reported to be associated with lymphatic development.
Lymphedema Clinic at Memorial Hermann Hospital in the Texas Medical Center, Houston
UT Physicians Pediatric Surgery Clinic, Houston
Wound Care Clinic at CHI St. Luke's The Woodland's Hospital, The Woodlands
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Cancer Institute (NCI)
NIH
Lymphatic Malformation Institute
OTHER
Lipedema Foundation
OTHER
The University of Texas Health Science Center, Houston
OTHER